Macroalbuminuria and Renal Pathology in First Nation Youth with Type 2 Diabetes Mellitus

  1. Elizabeth A.C. Sellers, MD (esellers{at}exchange.hsc.mb.ca),
  2. Tom D. Blydt-Hansen, MD,
  3. Heather J. Dean, MD,
  4. Ian W. Gibson, MD,
  5. Patricia E. Birk, MD and
  6. Malcolm Ogborn, MBBS
  1. Department of Pediatrics and Child Health, University of Manitoba
  2. Department of Pathology, University of Manitoba
  3. Northern Medical Program, University of British Columbia

    Abstract

    Objective: to determine the prevalence of macroalbuminuria and to describe the clinical and renal pathological changes associated with macroalbuminuria in a population of Canadian First Nation children and adolescents with type 2 diabetes.

    Research Design and Methods: We conducted a retrospective chart review at a single, tertiary care pediatric diabetes centre and a case series was constructed. We collected data on micro (≥ 3mg/mmol creatinine [26.5 mg/g]) and macroalbuminuria (≥ 28 mg/mmol creatinine [247.5 mg/g]), eGFR, renal pathology, aggravating risk factors (poor glycemic control, obesity, hypertension, glomerular hyperfiltration, hypercholesterolemia, smoking, exposure to diabetes in utero) were extracted from the charts.

    Results: We reviewed 90 charts of children and adolescents with type 2 diabetes. 53% had at least one random urine albumin: creatinine ratio (ACR) ≥ 3 mg/mmol (26.5 mg/g). 14/90 (16%) had persistent macroalbuminuria at, or within 8 years of diagnosis of diabetes. Of these 14 subjects, one had orthostatic albuminuria and 3 had spontaneous resolution of albuminuria. 10 had renal biopsies performed. 9/10 exhibited immune complex disease or glomerulosclerosis and none had classic diabetic nephropathy.

    Conclusions: this study suggests that the diagnosis of renal disease in children with type 2 diabetes cannot be reliably determined by clinical and laboratory findings alone. Renal biopsy is necessary for accurate diagnosis of renal disease in children and adolescents with type 2 diabetes and macroalbuminuria. The additional burden of non-diabetic kidney disease may explain the high rate of progression to end-stage kidney failure in this population.

    Footnotes

      • Received October 7, 2008.
      • Accepted February 7, 2009.